EmailStory Stocks®
Archive
Last Update: 06-Jan-12 01:50 ET
Family Dollar trades lower after hours following earnings
There were a number of stocks moving in after hours, including the following.
After Hours Gainers:
Companies trading higher in after hours in reaction to earnings: APOL +0.6%.
Companies trading higher in after hours in reaction to news: VPHM +4.8% (ViroPharma sees 2012 revs of $600-660 mln vs. $590.4 mln Capital IQ Estimates), ACHC +3.8% (Acadia Healthcare to acquire three inpatient psychiatric hospitals for $91 mln in cash; expect this accretive transaction will produce incremental annualized earnings of ~$0.20-0.22/share).
After Hours Losers:
Companies trading lower in after hours in reaction to earnings: RT -4.5%, FDO -2.8%.
Companies trading lower in after hours in reaction to news: DRRX -47.5% (Durect announces top-line data from BESST (POSIDUR U.S. Pivotal Phase III Trial); did not reach statistical significance).
RFMD -15.4% (sees Q3 revenues of $225 mln, below $250 mln CIQ Estimates), IART -9.8% (Integra issues Q4 prelim revs of ~$202-203 mln vs. $231.1 mln CIQ Estimates; sees EPS of $0.65-0.70 vs. $0.67 consensus).
CHTP -4.0% (Chelsea Therapeutics announced a $20 mln common stock offering pursuant to its existing shelf registration), AA -1.7% (Alcoa announces it intends to close or curtail approx 531K metric tons of its smelting capacity (approx 12% of global production)).
After Hours Gainers:
Companies trading higher in after hours in reaction to earnings: APOL +0.6%.
Companies trading higher in after hours in reaction to news: VPHM +4.8% (ViroPharma sees 2012 revs of $600-660 mln vs. $590.4 mln Capital IQ Estimates), ACHC +3.8% (Acadia Healthcare to acquire three inpatient psychiatric hospitals for $91 mln in cash; expect this accretive transaction will produce incremental annualized earnings of ~$0.20-0.22/share).
After Hours Losers:
Companies trading lower in after hours in reaction to earnings: RT -4.5%, FDO -2.8%.
Companies trading lower in after hours in reaction to news: DRRX -47.5% (Durect announces top-line data from BESST (POSIDUR U.S. Pivotal Phase III Trial); did not reach statistical significance).
RFMD -15.4% (sees Q3 revenues of $225 mln, below $250 mln CIQ Estimates), IART -9.8% (Integra issues Q4 prelim revs of ~$202-203 mln vs. $231.1 mln CIQ Estimates; sees EPS of $0.65-0.70 vs. $0.67 consensus).
CHTP -4.0% (Chelsea Therapeutics announced a $20 mln common stock offering pursuant to its existing shelf registration), AA -1.7% (Alcoa announces it intends to close or curtail approx 531K metric tons of its smelting capacity (approx 12% of global production)).
